Pennsylvania Op-Ed Argues Legalization Should Give Smaller Cannabis Businesses a Chance to Compete

6 days ago 10

An industry founder’s argument — and the unchanged legal reality that no adult-use law has passed — frame the state’s next debate.

Pennsylvania’s long-running marijuana legalization debate gained a new voice this week, and it came from inside the industry. In an op-ed published by Marijuana Moment on November 13, Gabe Perlow of Tri-Mountain Pure argued that if Pennsylvania legalizes adult-use cannabis, the law should be designed so smaller businesses have a realistic chance to compete — not simply so the companies already operating in the state’s medical market can serve more customers. This article reports what Perlow argued, who he is, and where Pennsylvania law actually stands. On that last point, precision matters: no adult-use legalization bill has passed in Pennsylvania. What changed, in Perlow’s account and in other recent reporting, is the political arithmetic in Harrisburg — not the law.

The Author And His Argument

Perlow writes from a particular vantage point. He helped build PurePenn, one of the first twelve grower/processor permittees in Pennsylvania’s medical marijuana program, and later transitioned that business to Trulieve’s management. He has since returned to the commonwealth’s medical program with a grower-processor operation that, by his account, has been operating for approximately six months, with products now available in nearly all Pennsylvania dispensaries. “I have experience in Pennsylvania’s medical marijuana program as a founder who sold a business and an entrepreneur who came back to build another company,” he wrote — while also acknowledging that his successful exit gave him “experience and resources that many aspiring entrepreneurs do not have,” and that “the next Pennsylvania founder should not need to have sold a cannabis company already to have a realistic chance of building one.”

The op-ed opens with a political claim: under Governor Josh Shapiro, the state Senate has flipped to a Democratic majority, giving the party a governing trifecta in the commonwealth for the first time since the early 1990s. “There is no better time to pass adult-use cannabis legislation in Pennsylvania than right now,” Perlow wrote. His central concern is market concentration. Citing recent reporting that six companies operate more than half of Pennsylvania’s medical marijuana dispensaries, he argued the question of who owns retail cannabis businesses is legitimate — but that keeping the current medical-only system is not the answer to it. “Legalization alone does not guarantee a competitive market,” he wrote, “and simply allowing existing companies to serve more customers would fall short of what Pennsylvania needs.”

What Perlow Proposes

The op-ed’s prescriptions are specific. Lawmakers, Perlow argued, should build a framework that allows qualified existing operators to launch adult-use sales while establishing clear, timely pathways for new businesses to enter. Application requirements and fees should reflect the size and scope of an operation, and smaller entrepreneurs should have a practical route into cultivation, manufacturing and retail, with meaningful support for applicants from communities harmed by cannabis prohibition. He also argued that the name above a dispensary’s door does not tell the whole story: a store operated by a national company can be an important customer for a Pennsylvania producer, and independent producers, in his experience, can earn shelf space through product quality — while regulators should still scrutinize conduct that improperly blocks competing products from retail shelves. “Businesses should win shelf space through quality, reliability and customer demand,” he wrote.

His remaining points address the transition itself. A medical-only system, he argued, limits the customers licensed businesses can serve; opening a regulated market to adults 21 and older would create a larger customer base that can support investment in employees, production and new products. At the same time, he wrote, Pennsylvania must protect medical patients’ access to appropriate products, professional guidance and affordable medicine through the transition, and pair legalization with enforceable testing, accurate labeling, age verification and responsible packaging. Taxes, in his framing, should support public needs while allowing the regulated market to compete with purchases currently made outside it, and revenue should help deliver expungement and investment in communities affected by past enforcement. He closed by quoting Shapiro — “It’s time to get shit done” — and arguing the governor now has a House and Senate that can work with him as allies.

Where Pennsylvania Law Actually Stands

None of Perlow’s proposals is law, and the distinction is the most important fact in this story. Pennsylvania’s medical marijuana program has operated since 2016 under Act 16; adult-use possession and sales remain prohibited under state law. The political shift he cites is real but preliminary: reporting by 2822 News and others on the November 3 midterm elections describes Democrats securing a projected 26–24 majority in the 50-seat state Senate while keeping the House and the governorship — the party’s first trifecta since the early 1990s — with the new legislative session beginning in January 2027. A flipped Senate changes who controls the calendar. It does not itself legalize anything.

The most developed adult-use proposal on the table illustrates the distance still to travel. Senate Bill 120, a bipartisan measure from Senator Dan Laughlin (R-Erie) and Senator Sharif Street (D-Philadelphia), would, as introduced, allow adults 21 and older to possess up to 30 grams of flower, apply an 8 percent excise tax on top of the state’s 6 percent sales tax, and create a Pennsylvania Cannabis Control Board. As Beard Bros Pharms reported, SB 120 sat in the Senate Law and Justice Committee for nearly a year and, as of its reporting, was still awaiting a committee vote — a bill, not a law. Even the market structure remains unsettled: Beard Bros counts four models circulating in Harrisburg, from independent private retail licensing and expansion of existing medical operators to social-equity-focused licensing and state-run stores modeled on Pennsylvania’s wine and spirits shops, with no model formally chosen.

The Stakes Around The Debate

The financial context explains the urgency on all sides. Pennsylvania’s medical program generated more than $1.6 billion in 2024 revenue, by the figure Beard Bros attributes to NORML’s Chris Goldstein via Spotlight PA, and Shapiro’s 2026 budget proposal projected $729.4 million in first-year revenue from legalization. Every neighboring state except West Virginia — Ohio, New York, Maryland, New Jersey and Delaware among them — now operates a legal adult-use market, while Pennsylvania residents cross state lines to buy. Meredith Buettner Schneider of the Pennsylvania Cannabis Coalition made a version of Perlow’s market-structure point in comments reported by 2822 News, calling for “a market structure that creates opportunities for small businesses” and “meaningful pathways for social equity applicants.” That convergence — an industry founder’s op-ed and an industry coalition’s statement landing on the same design question — suggests the next phase of Pennsylvania’s debate will be less about whether to legalize than about who gets to participate if it happens. What happens next is a legislative question, and as of this writing it remains unanswered: no adult-use bill has passed, and the new Senate majority takes its seats in January.

The post Pennsylvania Op-Ed Argues Legalization Should Give Smaller Cannabis Businesses a Chance to Compete appeared first on The Hype Magazine.

Read Entire Article